Matches in Wikidata for { <http://www.wikidata.org/entity/Q90345814> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90345814 description "article scientifique publié en 2018" @default.
- Q90345814 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90345814 description "scientific article published on 17 July 2018" @default.
- Q90345814 description "wetenschappelijk artikel" @default.
- Q90345814 description "наукова стаття, опублікована в липні 2018" @default.
- Q90345814 name "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 name "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 type Item @default.
- Q90345814 label "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 label "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 prefLabel "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 prefLabel "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 P1433 Q90345814-DCEF0C1A-9743-44FB-84F3-DA9B1E65DC0A @default.
- Q90345814 P1476 Q90345814-3B6EDB2D-1AFB-4528-B393-4B1B28E1ED10 @default.
- Q90345814 P2093 Q90345814-10385707-59FB-4C43-A094-041F277DF273 @default.
- Q90345814 P2093 Q90345814-281F8C99-4C87-4287-9657-48251B79122C @default.
- Q90345814 P2093 Q90345814-458080F4-33F1-48A8-814A-5E26DE09B192 @default.
- Q90345814 P2093 Q90345814-CB56A297-9AEC-4973-B4A5-9B57F1730924 @default.
- Q90345814 P304 Q90345814-E8B5938D-9730-47CC-8250-D6D31080C320 @default.
- Q90345814 P31 Q90345814-D7AAB700-0FB1-40C0-85F4-9673417C2486 @default.
- Q90345814 P356 Q90345814-C232A8A4-C945-40BA-96D3-712F632C72BA @default.
- Q90345814 P433 Q90345814-18C08D62-6D0A-4F07-89CF-38016BAB1AB1 @default.
- Q90345814 P478 Q90345814-AE419689-F563-4284-9F1E-EA4564520803 @default.
- Q90345814 P50 Q90345814-6DD473C9-E79C-4322-B292-88775FA04DF8 @default.
- Q90345814 P577 Q90345814-FCC90467-1252-4D9A-BB8E-7CF3A2357C41 @default.
- Q90345814 P698 Q90345814-40FB4AF8-D684-4832-96E9-F09FB60FEE14 @default.
- Q90345814 P921 Q90345814-4BF26D17-23D3-4F3C-8583-280FB00632D1 @default.
- Q90345814 P356 J.EURONEURO.2018.06.005 @default.
- Q90345814 P698 30025751 @default.
- Q90345814 P1433 Q15286536 @default.
- Q90345814 P1476 "Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial" @default.
- Q90345814 P2093 "Jan P A M Bogers" @default.
- Q90345814 P2093 "Peter F J Schulte" @default.
- Q90345814 P2093 "Peter Moleman" @default.
- Q90345814 P2093 "Theo G Broekman" @default.
- Q90345814 P304 "1024-1034" @default.
- Q90345814 P31 Q13442814 @default.
- Q90345814 P356 "10.1016/J.EURONEURO.2018.06.005" @default.
- Q90345814 P433 "9" @default.
- Q90345814 P478 "28" @default.
- Q90345814 P50 Q49504664 @default.
- Q90345814 P577 "2018-07-17T00:00:00Z" @default.
- Q90345814 P698 "30025751" @default.
- Q90345814 P921 Q41112 @default.